|
AbCellera Biologics Inc.
|
-0.51 USD
|
-20896.078%
|
|
Alkermes plc
|
2.14 USD
|
5103.738%
|
|
Agenus Inc.
|
-13.75 USD
|
-678.764%
|
|
Aptorum Group Limited
|
-0.62 USD
|
-17170.968%
|
|
Ardelyx, Inc.
|
-0.30 USD
|
-35593.333%
|
|
Dyadic International, Inc.
|
-0.24 USD
|
-44516.667%
|
|
Eton Pharmaceuticals, Inc.
|
-0.04 USD
|
-293269.863%
|
|
Lantern Pharma Inc.
|
-1.47 USD
|
-7184.354%
|
|
Inhibikase Therapeutics, Inc.
|
-3.57 USD
|
-2899.44%
|
|
Novavax, Inc.
|
-5.41 USD
|
-1879.298%
|
|
Janux Therapeutics, Inc.
|
-1.32 USD
|
-8012.121%
|
|
Pyxis Oncology, Inc.
|
-1.85 USD
|
-5688.108%
|
|
TransCode Therapeutics, Inc.
|
-103.61 USD
|
-3.349%
|
|
Ocuphire Pharma, Inc.
|
-0.46 USD
|
-23178.261%
|
|
Outlook Therapeutics, Inc.
|
-4.72 USD
|
-2168.644%
|
|
Madrigal Pharmaceuticals, Inc.
|
-19.99 USD
|
-435.668%
|
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
-8466.4%
|
|
SELLAS Life Sciences Group, Inc.
|
-1.34 USD
|
-7891.045%
|
|
Syros Pharmaceuticals, Inc.
|
-5.81 USD
|
-1743.029%
|
|
Barinthus Biotherapeutics plc
|
-1.91 USD
|
-5506.283%
|
|
Windtree Therapeutics, Inc.
|
-92.23 USD
|
-16.101%
|
|
Xeris Biopharma Holdings, Inc.
|
-0.45 USD
|
-23695.556%
|
|
Clearside Biomedical, Inc.
|
-0.53 USD
|
-20103.774%
|
|
C4 Therapeutics, Inc.
|
-2.67 USD
|
-3910.487%
|
|
Alnylam Pharmaceuticals, Inc.
|
-3.52 USD
|
-2942.045%
|
|
AlloVir, Inc.
|
-1.83 USD
|
-5751.366%
|
|
Arrowhead Pharmaceuticals, Inc.
|
-1.91 USD
|
-5506.283%
|
|
VYNE Therapeutics Inc.
|
-2.77 USD
|
-3765.704%
|
|
Bicycle Therapeutics plc
|
-5.08 USD
|
-2007.874%
|
|
BioXcel Therapeutics, Inc.
|
-6.15 USD
|
-1641.138%
|
|
ChromaDex Corporation
|
-0.07 USD
|
-162388.619%
|
|
Chimerix, Inc.
|
-0.93 USD
|
-11413.978%
|
|
Corbus Pharmaceuticals Holdings, Inc.
|
-10.31 USD
|
-938.603%
|
|
Caribou Biosciences, Inc.
|
-1.38 USD
|
-7659.42%
|
|
CRISPR Therapeutics AG
|
-1.94 USD
|
-5419.588%
|
|
Precision BioSciences, Inc.
|
-15.96 USD
|
-570.927%
|
|
Fate Therapeutics, Inc.
|
-1.64 USD
|
-6429.268%
|
|
Fortress Biotech, Inc.
|
-8.47 USD
|
-1164.227%
|
|
Fortress Biotech, Inc.
|
-8.47 USD
|
-1164.227%
|
|
HOOKIPA Pharma Inc.
|
-8.63 USD
|
-1140.788%
|
|
ImmuCell Corporation
|
-0.75 USD
|
-14177.333%
|
|
IDEAYA Biosciences, Inc.
|
-1.96 USD
|
-5363.265%
|
|
Immix Biopharma, Inc.
|
-0.89 USD
|
-11931.461%
|
|
Incyte Corporation
|
2.67 USD
|
4110.487%
|
|
Innoviva, Inc.
|
2.92 USD
|
3767.123%
|
|
IO Biotech, Inc.
|
-1.98 USD
|
-5308.081%
|
|
Jaguar Health, Inc.
|
-107.42 USD
|
0.317%
|
|
Keros Therapeutics, Inc.
|
-5.20 USD
|
-1959.231%
|
|
Ligand Pharmaceuticals Incorporated
|
3.02 USD
|
3645.695%
|
|
ContextLogic Inc.
|
-13.36 USD
|
-701.497%
|
|
MiMedx Group, Inc.
|
0.48 USD
|
22408.333%
|
|
MEI Pharma, Inc.
|
2.67 USD
|
4110.487%
|
|
NextCure, Inc.
|
-2.25 USD
|
-4659.111%
|
|
Onconetix, Inc.
|
-2.19 USD
|
-4789.498%
|
|
Oncternal Therapeutics, Inc.
|
-13.43 USD
|
-697.319%
|
|
Opthea Limited
|
-0.35 USD
|
-30494.286%
|
|
Psyence Biomedical Ltd.
|
-7.85 USD
|
-1264.076%
|
|
Vaxcyte, Inc.
|
-4.14 USD
|
-2486.473%
|
|
PDS Biotechnology Corporation
|
-1.39 USD
|
-7603.597%
|
|
Precigen, Inc.
|
-0.39 USD
|
-27356.41%
|
|
Pharming Group N.V.
|
-0.16 USD
|
-66825.0%
|
|
Phathom Pharmaceuticals, Inc.
|
-3.93 USD
|
-2624.682%
|
|
Pieris Pharmaceuticals, Inc.
|
-21.80 USD
|
-391.193%
|
|
PureTech Health plc
|
-2.38 USD
|
-4399.16%
|
|
Rigel Pharmaceuticals, Inc.
|
-1.44 USD
|
-7336.111%
|
|
Avidity Biosciences, Inc.
|
-2.91 USD
|
-3579.725%
|
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
-8466.4%
|
|
Sangamo Therapeutics, Inc.
|
-1.48 USD
|
-7135.135%
|
|
Sol-Gel Technologies Ltd.
|
-1.01 USD
|
-10501.98%
|
|
Acelyrin, Inc.
|
-5.43 USD
|
-1872.007%
|
|
Salarius Pharmaceuticals, Inc.
|
-0.00 USD
|
-2817794.737%
|
|
Summit Therapeutics Inc.
|
-0.99 USD
|
-10716.162%
|
|
Sensei Biotherapeutics, Inc.
|
-1.22 USD
|
-8677.049%
|
|
Senti Biosciences, Inc.
|
-16.01 USD
|
-568.832%
|
|
Stoke Therapeutics, Inc.
|
-2.38 USD
|
-4399.16%
|
|
Elevation Oncology, Inc.
|
-1.34 USD
|
-7891.045%
|
|
Alaunos Therapeutics, Inc.
|
-21.97 USD
|
-387.392%
|
|
Telomir Pharmaceuticals, Inc. Common Stock
|
-0.44 USD
|
-24236.364%
|
|
Entrada Therapeutics, Inc.
|
-0.20 USD
|
-53440.0%
|
|
VistaGen Therapeutics, Inc.
|
-1.52 USD
|
-6944.737%
|
|
Kintara Therapeutics, Inc.
|
-3.23 USD
|
-3215.17%
|
|
Wave Life Sciences Ltd.
|
-0.54 USD
|
-19729.63%
|
|
Seer, Inc.
|
-1.35 USD
|
-7831.852%
|
|
Verrica Pharmaceuticals Inc.
|
-1.48 USD
|
-7135.135%
|
|
Aadi Bioscience, Inc.
|
-2.44 USD
|
-4288.525%
|
|
ESSA Pharma Inc.
|
-0.60 USD
|
-17746.667%
|
|
GlycoMimetics, Inc.
|
-0.58 USD
|
-18362.069%
|
|
GT Biopharma, Inc.
|
-5.64 USD
|
-1798.582%
|
|
Inhibrx Biosciences, Inc.
|
-5.12 USD
|
-1991.406%
|
|
Akebia Therapeutics, Inc.
|
-0.28 USD
|
-38142.857%
|
|
Catalyst Pharmaceuticals, Inc.
|
0.67 USD
|
16082.09%
|
|
Longboard Pharmaceuticals, Inc.
|
-2.39 USD
|
-4380.335%
|
|
Orchestra BioMed Holdings, Inc.
|
-1.48 USD
|
-7135.135%
|
|
Alzamend Neuro, Inc.
|
-14.72 USD
|
-627.446%
|
|
Sorrento Therapeutics, Inc.
|
-1.37 USD
|
-7716.058%
|
|
TRACON Pharmaceuticals, Inc.
|
-2.20 USD
|
-4767.273%
|
|
Viracta Therapeutics, Inc.
|
-1.32 USD
|
-8012.121%
|
|
Rocket Pharmaceuticals, Inc.
|
-2.92 USD
|
-3567.123%
|
|
Aptose Biosciences Inc.
|
-7.58 USD
|
-1312.665%
|
|
ZyVersa Therapeutics, Inc.
|
-1089.67 USD
|
90.173%
|
|
Soligenix, Inc.
|
-12.66 USD
|
-745.814%
|
|
Century Therapeutics, Inc.
|
-2.30 USD
|
-4555.652%
|
|
Kura Oncology, Inc.
|
-2.08 USD
|
-5048.077%
|
|
TScan Therapeutics, Inc.
|
-1.36 USD
|
-7773.529%
|
|
Intensity Therapeutics, Inc.
|
-1.38 USD
|
-7659.42%
|
|
Ocean Biomedical, Inc.
|
-0.03 USD
|
-407048.289%
|
|
CytomX Therapeutics, Inc.
|
-0.01 USD
|
-1390549.351%
|
|
Autolus Therapeutics plc
|
-1.20 USD
|
-8823.333%
|
|
Mineralys Therapeutics, Inc.
|
-1.99 USD
|
-5280.905%
|
|
EyePoint Pharmaceuticals, Inc.
|
-1.82 USD
|
-5783.516%
|
|
Eterna Therapeutics Inc.
|
-4.08 USD
|
-2524.51%
|
|
Adaptive Biotechnologies Corporation
|
-1.56 USD
|
-6764.103%
|
|
GRI Bio, Inc.
|
-28.25 USD
|
-279.044%
|
|
Xenetic Biosciences, Inc.
|
-2.71 USD
|
-3851.292%
|
|
Tenaya Therapeutics, Inc.
|
-1.68 USD
|
-6273.81%
|
|
IGM Biosciences, Inc.
|
-4.71 USD
|
-2173.461%
|
|
INmune Bio, Inc.
|
-1.67 USD
|
-6311.976%
|
|
Heron Therapeutics, Inc.
|
-0.80 USD
|
-13285.0%
|
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
-1301.571%
|
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
-746.482%
|
|
Entero Therapeutics, Inc.
|
-47.88 USD
|
-123.642%
|
|
Milestone Pharmaceuticals Inc.
|
-1.39 USD
|
-7603.597%
|
|
X4 Pharmaceuticals, Inc.
|
-0.57 USD
|
-18685.965%
|
|
Atara Biotherapeutics, Inc.
|
-65.18 USD
|
-64.284%
|
|
Coherus BioSciences, Inc.
|
-2.53 USD
|
-4132.411%
|
|
Verastem, Inc.
|
-3.96 USD
|
-2604.04%
|
|
Abeona Therapeutics Inc.
|
-2.53 USD
|
-4132.411%
|
|
Pliant Therapeutics, Inc.
|
-2.75 USD
|
-3793.818%
|
|
Tonix Pharmaceuticals Holding Corp.
|
-219.09 USD
|
51.125%
|
|
Histogen Inc.
|
-3.46 USD
|
-2994.798%
|
|
Aprea Therapeutics, Inc.
|
-3.95 USD
|
-2610.886%
|
|
Surrozen, Inc.
|
-21.33 USD
|
-402.016%
|
|
Organovo Holdings, Inc.
|
-1.60 USD
|
-6592.5%
|
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
-3925.564%
|
|
Ovid Therapeutics Inc.
|
-0.74 USD
|
-14370.27%
|
|
Panbela Therapeutics, Inc.
|
-232.42 Thousand USD
|
99.954%
|
|
CASI Pharmaceuticals, Inc.
|
-2.02 USD
|
-5200.99%
|
|
Cadrenal Therapeutics, Inc. Common Stock
|
-0.62 USD
|
-17170.968%
|
|
Centessa Pharmaceuticals plc
|
-1.57 USD
|
-6720.382%
|
|
Hepion Pharmaceuticals, Inc.
|
-12.32 USD
|
-769.156%
|
|
Arcturus Therapeutics Holdings Inc.
|
-1.12 USD
|
-9460.714%
|
|
BioRestorative Therapies, Inc.
|
-2.47 USD
|
-4235.223%
|
|
Apollomics, Inc.
|
-2.32 USD
|
-4515.517%
|
|
Amarin Corporation plc
|
-0.15 USD
|
-71286.667%
|
|
Mesoblast Limited
|
-0.89 USD
|
-11931.461%
|
|
Turnstone Biologics Corp.
|
-4.77 USD
|
-2144.864%
|
|
Kymera Therapeutics, Inc.
|
-2.52 USD
|
-4149.206%
|
|
Synaptogenix, Inc.
|
-29.56 USD
|
-262.246%
|
|
Tiziana Life Sciences Ltd
|
-0.16 USD
|
-66825.0%
|
|
Aurinia Pharmaceuticals Inc.
|
-0.54 USD
|
-19729.63%
|
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
-36824.138%
|
|
Monopar Therapeutics Inc.
|
-0.58 USD
|
-18362.069%
|
|
Exelixis, Inc.
|
0.65 USD
|
16573.846%
|
|
Better Therapeutics, Inc.
|
-1.69 USD
|
-6236.095%
|
|
Nurix Therapeutics, Inc.
|
-2.65 USD
|
-3940.755%
|
|
Apellis Pharmaceuticals, Inc.
|
-4.45 USD
|
-2306.292%
|
|
NLS Pharmaceutics AG
|
-0.32 USD
|
-33362.5%
|
|
Dermata Therapeutics, Inc.
|
-40.18 USD
|
-166.501%
|
|
Aridis Pharmaceuticals, Inc.
|
-1.64 USD
|
-6429.268%
|
|
Gritstone bio, Inc.
|
-1.20 USD
|
-8823.333%
|
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
-1632.686%
|
|
TNF Pharmaceuticals, Inc.
|
-5.33 USD
|
-1909.006%
|
|
Avid Bioservices, Inc.
|
-2.23 USD
|
-4701.794%
|
|
Insmed Incorporated
|
-5.34 USD
|
-1905.243%
|
|
Virpax Pharmaceuticals, Inc.
|
-12.97 USD
|
-725.598%
|
|
MediWound Ltd.
|
-0.75 USD
|
-14177.333%
|
|
OmniAb, Inc.
|
-0.51 USD
|
-20896.078%
|
|
Alector, Inc.
|
-1.56 USD
|
-6764.103%
|
|
Seres Therapeutics, Inc.
|
-0.89 USD
|
-11931.461%
|
|
Checkpoint Therapeutics, Inc.
|
-2.77 USD
|
-3765.704%
|
|
Zai Lab Limited
|
-3.46 USD
|
-2994.798%
|
|
Revance Therapeutics, Inc.
|
-3.83 USD
|
-2695.822%
|
|
Aura Biosciences, Inc.
|
-1.93 USD
|
-5448.187%
|
|
Lyell Immunopharma, Inc.
|
-0.93 USD
|
-11413.978%
|
|
Immunic, Inc.
|
-2.11 USD
|
-4974.882%
|
|
Tarsus Pharmaceuticals, Inc.
|
-4.62 USD
|
-2217.749%
|
|
Veracyte, Inc.
|
-1.02 USD
|
-10398.039%
|
|
InMed Pharmaceuticals Inc.
|
-1.01 USD
|
-10501.98%
|
|
FibroGen, Inc.
|
-2.92 USD
|
-3567.123%
|
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
-253.516%
|
|
Adial Pharmaceuticals, Inc.
|
-5.44 USD
|
-1868.382%
|
|
Sonnet BioTherapeutics Holdings, Inc.
|
-18.14 USD
|
-490.298%
|
|
Jazz Pharmaceuticals plc
|
6.95 USD
|
1640.719%
|
|
Cyclacel Pharmaceuticals, Inc.
|
-26.75 USD
|
-300.299%
|
|
Amylyx Pharmaceuticals, Inc.
|
0.73 USD
|
14768.493%
|
|
TG Therapeutics, Inc.
|
0.09 USD
|
120010.414%
|
|
Galecto, Inc.
|
-36.08 USD
|
-196.785%
|
|
Calithera Biosciences, Inc.
|
-7.94 USD
|
-1248.615%
|
|
Fortrea Holdings Inc.
|
-0.04 USD
|
-279482.245%
|
|
KalVista Pharmaceuticals, Inc.
|
-3.44 USD
|
-3012.791%
|
|
Aptevo Therapeutics Inc.
|
-62.62 USD
|
-71.0%
|
|
XBiotech Inc.
|
-0.81 USD
|
-13119.753%
|
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
-1632.686%
|
|
Lyra Therapeutics, Inc.
|
-1.26 USD
|
-8398.413%
|
|
Foghorn Therapeutics Inc.
|
-2.34 USD
|
-4476.068%
|
|
Y-mAbs Therapeutics, Inc.
|
-0.49 USD
|
-21753.061%
|
|
Theravance Biopharma, Inc.
|
-1.00 USD
|
-10608.0%
|
|
Ultragenyx Pharmaceutical Inc.
|
-8.25 USD
|
-1197.939%
|
|
Metagenomi, Inc. Common Stock
|
-1.82 USD
|
-5783.516%
|
|
Vaxxinity, Inc.
|
-0.45 USD
|
-23695.556%
|
|
BioCryst Pharmaceuticals, Inc.
|
-1.18 USD
|
-8974.576%
|
|
Gain Therapeutics, Inc.
|
-1.71 USD
|
-6161.988%
|
|
Cartesian Therapeutics, Inc.
|
-42.49 USD
|
-152.012%
|
|
NexImmune, Inc.
|
-30.82 USD
|
-247.437%
|
|
Creative Medical Technology Holdings, Inc.
|
-3.76 USD
|
-2747.872%
|
|
Marker Therapeutics, Inc.
|
-1.93 USD
|
-5448.187%
|
|
Regeneron Pharmaceuticals, Inc.
|
37.05 USD
|
389.015%
|
|
Chemomab Therapeutics Ltd.
|
-2.06 USD
|
-5098.058%
|
|
Scopus BioPharma Inc.
|
-0.55 USD
|
-19369.091%
|
|
RAPT Therapeutics, Inc.
|
-3.05 USD
|
-3410.82%
|
|
Ainos, Inc.
|
-3.36 USD
|
-3086.905%
|
|
Pluri Inc.
|
-3.99 USD
|
-2583.709%
|
|
Prothena Corporation plc
|
-2.76 USD
|
-3779.71%
|
|
Adaptimmune Therapeutics plc
|
-0.57 USD
|
-18685.965%
|
|
Celularity Inc.
|
-11.02 USD
|
-871.688%
|
|
Rallybio Corporation
|
-1.84 USD
|
-5719.565%
|
|
Cue Biopharma, Inc.
|
-1.11 USD
|
-9546.847%
|
|
MeiraGTx Holdings plc
|
-1.49 USD
|
-7086.577%
|
|
Omeros Corporation
|
-1.88 USD
|
-5595.745%
|
|
Humacyte, Inc.
|
-1.07 USD
|
-9907.477%
|
|
Immunocore Holdings plc
|
-1.13 USD
|
-9376.106%
|
|
Cocrystal Pharma, Inc.
|
-1.86 USD
|
-5656.989%
|
|
Cidara Therapeutics, Inc.
|
-5.25 USD
|
-1939.619%
|
|
Blueprint Medicines Corporation
|
-8.37 USD
|
-1179.331%
|
|
CalciMedica, Inc.
|
-7.65 USD
|
-1299.739%
|
|
Cabaletta Bio, Inc.
|
-1.65 USD
|
-6389.697%
|
|
Marinus Pharmaceuticals, Inc.
|
-2.63 USD
|
-3971.483%
|
|
Scholar Rock Holding Corporation
|
-1.99 USD
|
-5280.905%
|
|
Sana Biotechnology, Inc.
|
-1.46 USD
|
-7234.247%
|
|
Pulmatrix, Inc.
|
-3.87 USD
|
-2666.925%
|
|
Elicio Therapeutics, Inc.
|
-6.96 USD
|
-1438.506%
|
|
Vigil Neuroscience, Inc.
|
-2.13 USD
|
-4927.23%
|
|
Intellia Therapeutics, Inc.
|
-5.42 USD
|
-1875.646%
|
|
Adlai Nortye Ltd. American Depositary Shares
|
-7.26 USD
|
-1374.931%
|
|
Cytokinetics, Incorporated
|
-5.45 USD
|
-1864.771%
|
|
Eloxx Pharmaceuticals, Inc.
|
-16.65 USD
|
-543.123%
|
|
Nutriband Inc.
|
-0.69 USD
|
-15418.841%
|
|
Protara Therapeutics, Inc.
|
-3.57 USD
|
-2899.44%
|
|
Vor Biopharma Inc.
|
-1.75 USD
|
-6018.857%
|
|
Roivant Sciences Ltd.
|
5.55 USD
|
2029.369%
|
|
Evogene Ltd.
|
-5.23 USD
|
-1947.419%
|
|
ProKidney Corp.
|
-0.57 USD
|
-18685.965%
|
|
Applied Therapeutics, Inc.
|
-1.42 USD
|
-7440.845%
|
|
Hoth Therapeutics, Inc.
|
-2.30 USD
|
-4555.652%
|
|
BridgeBio Pharma, Inc.
|
-3.95 USD
|
-2610.886%
|
|
CorMedix Inc.
|
-0.91 USD
|
-11667.033%
|
|
BioLineRx Ltd.
|
-0.94 USD
|
-11291.489%
|
|
Tango Therapeutics, Inc.
|
-1.08 USD
|
-9814.815%
|
|
Galectin Therapeutics Inc.
|
-0.74 USD
|
-14370.27%
|
|
Atai Life Sciences N.V.
|
-0.25 USD
|
-42732.0%
|
|
Renovaro Biosciences Inc.
|
-0.84 USD
|
-12647.619%
|
|
Aerovate Therapeutics, Inc.
|
-2.87 USD
|
-3631.01%
|
|
Zentalis Pharmaceuticals, Inc.
|
-4.47 USD
|
-2295.526%
|
|
Sagimet Biosciences Inc.
|
-2.66 USD
|
-3925.564%
|
|
MediciNova, Inc.
|
-0.17 USD
|
-62888.235%
|
|
Praxis Precision Medicines, Inc.
|
-18.69 USD
|
-472.927%
|
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
-16124.242%
|
|
GeoVax Labs, Inc.
|
-10.22 USD
|
-947.75%
|
|
Axsome Therapeutics, Inc.
|
-5.27 USD
|
-1931.879%
|
|
Biomea Fusion, Inc.
|
-3.44 USD
|
-3012.791%
|
|
PTC Therapeutics, Inc.
|
-8.37 USD
|
-1179.331%
|
|
Mereo BioPharma Group plc
|
-0.04 USD
|
-239452.573%
|
|
Cullinan Oncology, Inc.
|
-3.69 USD
|
-2801.897%
|
|
Syndax Pharmaceuticals, Inc.
|
-2.98 USD
|
-3493.289%
|
|
Absci Corporation
|
-1.20 USD
|
-8823.333%
|
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
-2590.452%
|
|
4D Molecular Therapeutics, Inc.
|
-2.58 USD
|
-4050.388%
|
|
Dyne Therapeutics, Inc.
|
-3.95 USD
|
-2610.886%
|
|
Kiniksa Pharmaceuticals, Ltd.
|
0.20 USD
|
53640.0%
|
|
Ventyx Biosciences, Inc.
|
-3.30 USD
|
-3144.848%
|
|
Allakos Inc.
|
-2.14 USD
|
-4903.738%
|
|
Imunon, Inc.
|
-2.16 USD
|
-4857.407%
|
|
Fulcrum Therapeutics, Inc.
|
-1.59 USD
|
-6634.591%
|
|
Corcept Therapeutics Incorporated
|
1.02 USD
|
10598.039%
|
|
BioAtla, Inc.
|
-2.58 USD
|
-4050.388%
|
|
NLS Pharmaceutics AG
|
-0.32 USD
|
-33362.5%
|
|
Bio-Path Holdings, Inc.
|
-33.64 USD
|
-218.312%
|
|
Allogene Therapeutics, Inc.
|
-2.09 USD
|
-5023.445%
|
|
Larimar Therapeutics, Inc.
|
-0.84 USD
|
-12647.619%
|
|
XOMA Corporation
|
-4.04 USD
|
-2550.495%
|
|
Kezar Life Sciences, Inc.
|
-1.40 USD
|
-7548.571%
|
|
Cara Therapeutics, Inc.
|
-2.19 USD
|
-4789.498%
|
|
aTyr Pharma, Inc.
|
-0.94 USD
|
-11291.489%
|
|
Aligos Therapeutics, Inc.
|
-3.52 USD
|
-2942.045%
|
|
Akero Therapeutics, Inc.
|
-2.89 USD
|
-3605.19%
|
|
Viridian Therapeutics, Inc.
|
-5.31 USD
|
-1916.573%
|
|
Eliem Therapeutics, Inc.
|
-1.30 USD
|
-8136.923%
|
|
EyeGate Pharmaceuticals, Inc.
|
-2.54 USD
|
-4115.748%
|
|
Akari Therapeutics, Plc
|
-2.04 USD
|
-5149.02%
|
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
-26769900.0%
|
|
Halozyme Therapeutics, Inc.
|
2.13 USD
|
5127.23%
|
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
-10501.98%
|
|
UroGen Pharma Ltd.
|
-3.55 USD
|
-2916.338%
|
|
Sutro Biopharma, Inc.
|
-1.78 USD
|
-5915.73%
|
|
ZIVO Bioscience, Inc.
|
-4.60 USD
|
-2227.826%
|
|
Orgenesis Inc.
|
-1.91 USD
|
-5506.283%
|
|
Entera Bio Ltd.
|
-0.31 USD
|
-34441.935%
|
|
GH Research PLC
|
-0.68 USD
|
-15647.059%
|
|
Lisata Therapeutics, Inc.
|
-2.58 USD
|
-4050.388%
|
|
Reneo Pharmaceuticals, Inc.
|
-25.23 USD
|
-324.415%
|
|
Xencor, Inc.
|
-2.08 USD
|
-5048.077%
|
|
60 Degrees Pharmaceuticals, Inc.
|
-0.95 USD
|
-11171.579%
|
|
Replimune Group, Inc.
|
-3.24 USD
|
-3204.938%
|
|
Coeptis Therapeutics Holdings, Inc.
|
-0.83 USD
|
-12801.205%
|
|
Vanda Pharmaceuticals Inc.
|
0.04 USD
|
245134.325%
|
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
-10501.98%
|
|
Portage Biotech Inc.
|
-3.70 USD
|
-2794.054%
|
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
-16124.242%
|
|
Olema Pharmaceuticals, Inc.
|
-2.14 USD
|
-4903.738%
|
|
OncoCyte Corporation
|
-3.75 USD
|
-2755.467%
|
|
Qualigen Therapeutics, Inc.
|
-2.46 USD
|
-4252.846%
|
|
Processa Pharmaceuticals, Inc.
|
-8.48 USD
|
-1162.736%
|
|
Purple Biotech Ltd.
|
-0.09 USD
|
-119142.762%
|
|
CollPlant Biotechnologies Ltd.
|
-0.62 USD
|
-17170.968%
|
|
scPharmaceuticals Inc.
|
-1.42 USD
|
-7440.845%
|
|
ProMIS Neurosciences, Inc.
|
-1.42 USD
|
-7440.845%
|
|
HilleVax, Inc.
|
-3.04 USD
|
-3422.368%
|
|
NeuroSense Therapeutics Ltd.
|
-0.83 USD
|
-12801.205%
|
|
Genprex, Inc.
|
-22.58 USD
|
-374.225%
|
|
Neumora Therapeutics, Inc. Common Stock
|
-1.49 USD
|
-7086.577%
|
|
Atossa Therapeutics, Inc.
|
-0.24 USD
|
-44516.667%
|
|
XTL Biopharmaceuticals Ltd.
|
-0.00 USD
|
-3244748.485%
|
|
Virios Therapeutics, Inc.
|
-0.28 USD
|
-38142.857%
|
|
OKYO Pharma Limited
|
-0.00 USD
|
-17846566.667%
|
|
Savara Inc.
|
-0.33 USD
|
-32348.485%
|
|
Curis, Inc.
|
-8.96 USD
|
-1095.089%
|
|
Daré Bioscience, Inc.
|
-4.15 USD
|
-2480.241%
|
|
Carmell Therapeutics Corporation
|
-1.46 USD
|
-7234.247%
|
|
Titan Pharmaceuticals, Inc.
|
-7.41 USD
|
-1345.074%
|
|
Achieve Life Sciences, Inc.
|
-1.50 USD
|
-7038.667%
|
|
BeiGene, Ltd.
|
-8.45 USD
|
-1167.219%
|
|
Kiromic BioPharma, Inc.
|
-21.41 USD
|
-400.14%
|
|
Revolution Medicines, Inc. Warrant
|
-3.86 USD
|
-2674.093%
|
|
Protagonist Therapeutics, Inc.
|
-1.39 USD
|
-7603.597%
|
|
Erasca, Inc.
|
-0.83 USD
|
-12801.205%
|
|
bluebird bio, Inc.
|
-1.93 USD
|
-5448.187%
|
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
-9211.304%
|
|
BioMarin Pharmaceutical Inc.
|
0.89 USD
|
12131.461%
|
|
DBV Technologies S.A.
|
-0.76 USD
|
-13989.474%
|
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
-9211.304%
|
|
Moderna, Inc.
|
-12.34 USD
|
-767.747%
|
|
Vincerx Pharma, Inc.
|
-1.89 USD
|
-5565.608%
|
|
Fresh Tracks Therapeutics, Inc.
|
-0.96 USD
|
-11054.167%
|
|
Molecular Templates, Inc.
|
-1.80 USD
|
-5848.889%
|
|
Acrivon Therapeutics, Inc. Common Stock
|
-2.74 USD
|
-3808.029%
|
|
Travere Therapeutics, Inc.
|
-1.50 USD
|
-7038.667%
|
|
Monte Rosa Therapeutics, Inc.
|
-2.63 USD
|
-3971.483%
|
|
Spruce Biosciences, Inc.
|
-1.24 USD
|
-8535.484%
|
|
Celldex Therapeutics, Inc.
|
-2.92 USD
|
-3567.123%
|
|
Cogent Biosciences, Inc.
|
-2.42 USD
|
-4324.793%
|
|
MacroGenics, Inc.
|
-0.15 USD
|
-71286.667%
|
|
RenovoRx, Inc.
|
-0.99 USD
|
-10716.162%
|
|
Adicet Bio, Inc.
|
-3.31 USD
|
-3135.045%
|
|
Prime Medicine, Inc.
|
-2.18 USD
|
-4811.927%
|
|
Aditxt, Inc.
|
-4326.64 USD
|
97.525%
|
|
Adagene Inc.
|
-0.44 USD
|
-24236.364%
|
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
-50890.476%
|
|
Quantum-Si incorporated
|
-0.68 USD
|
-15647.059%
|
|
Maravai LifeSciences Holdings, Inc.
|
-0.90 USD
|
-11797.778%
|
|
Acurx Pharmaceuticals, Inc.
|
-1.15 USD
|
-9211.304%
|
|
Voyager Therapeutics, Inc.
|
3.08 USD
|
3576.623%
|
|
SciSparc Ltd.
|
-14.43 USD
|
-642.065%
|
|
Vericel Corporation
|
-0.07 USD
|
-159959.791%
|
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
-20103.774%
|
|
Minerva Neurosciences, Inc.
|
-4.61 USD
|
-2222.777%
|
|
Generation Bio Co.
|
-1.96 USD
|
-5363.265%
|
|
Astria Therapeutics, Inc.
|
-2.42 USD
|
-4324.793%
|
|
Black Diamond Therapeutics, Inc.
|
-1.88 USD
|
-5595.745%
|
|
Arcutis Biotherapeutics, Inc.
|
-3.78 USD
|
-2732.804%
|
|
Invivyd, Inc.
|
-1.81 USD
|
-5816.022%
|
|
Relay Therapeutics, Inc.
|
-2.79 USD
|
-3737.993%
|
|
Quoin Pharmaceuticals, Ltd.
|
-9.64 USD
|
-1010.788%
|
|
Spero Therapeutics, Inc.
|
0.43 USD
|
25002.326%
|
|
Artelo Biosciences, Inc.
|
-3.49 USD
|
-2968.195%
|
|
2seventy bio, Inc.
|
-4.42 USD
|
-2322.624%
|
|
ADMA Biologics, Inc.
|
-0.13 USD
|
-82269.231%
|
|
Clene Inc.
|
-9.43 USD
|
-1035.525%
|
|
Capricor Therapeutics, Inc.
|
-0.83 USD
|
-12801.205%
|
|
Boundless Bio, Inc. Common Stock
|
-2.22 USD
|
-4723.423%
|
|
GeoVax Labs, Inc.
|
-10.22 USD
|
-947.75%
|
|
Recursion Pharmaceuticals, Inc.
|
-1.58 USD
|
-6677.215%
|
|
Citius Pharmaceuticals, Inc.
|
-0.22 USD
|
-48572.727%
|
|
Contineum Therapeutics, Inc. Class A Common Stock
|
1.36 USD
|
7973.529%
|
|
Relmada Therapeutics, Inc.
|
-3.28 USD
|
-3164.634%
|
|
Finch Therapeutics Group, Inc.
|
-46.59 USD
|
-129.835%
|
|
ALX Oncology Holdings Inc.
|
-3.74 USD
|
-2763.102%
|
|
Vir Biotechnology, Inc.
|
-4.59 USD
|
-2232.898%
|
|
Evaxion Biotech A/S
|
-8.11 USD
|
-1220.345%
|
|
Ocular Therapeutix, Inc.
|
-1.09 USD
|
-9723.853%
|
|
Verve Therapeutics, Inc.
|
-3.12 USD
|
-3332.051%
|
|
Trevena, Inc.
|
-54.51 USD
|
-96.441%
|
|
Surrozen, Inc.
|
-21.33 USD
|
-402.016%
|
|
Tyra Biosciences, Inc.
|
-1.62 USD
|
-6509.877%
|
|
Cingulate Inc.
|
-311.99 USD
|
65.678%
|
|
Galmed Pharmaceuticals Ltd.
|
-30.05 USD
|
-256.339%
|
|
Unity Biotechnology, Inc.
|
-2.70 USD
|
-3865.926%
|
|
Tenax Therapeutics, Inc.
|
-31.09 USD
|
-244.419%
|
|
Terns Pharmaceuticals, Inc.
|
-1.27 USD
|
-8331.496%
|
|
ACADIA Pharmaceuticals Inc.
|
-0.37 USD
|
-28840.541%
|
|
Connect Biopharma Holdings Limited
|
-1.08 USD
|
-9814.815%
|
|
Clearmind Medicine Inc.
|
-59.18 USD
|
-80.94%
|
|
Kronos Bio, Inc.
|
-1.95 USD
|
-5391.282%
|
|
Bolt Biotherapeutics, Inc.
|
-1.83 USD
|
-5751.366%
|
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
-27356.41%
|
|
Viking Therapeutics, Inc.
|
-0.91 USD
|
-11667.033%
|
|
Statera Biopharma, Inc.
|
-4.97 USD
|
-2054.527%
|
|
ImmunityBio, Inc.
|
-1.15 USD
|
-9211.304%
|
|
Korro Bio, Inc.
|
-53.08 USD
|
-101.733%
|
|
Kineta, Inc.
|
-1.28 USD
|
-8265.625%
|
|
BioVie Inc.
|
-7.30 USD
|
-1366.849%
|
|
Codexis, Inc.
|
-1.12 USD
|
-9460.714%
|
|
Celularity Inc.
|
-11.02 USD
|
-871.688%
|
|
Crinetics Pharmaceuticals, Inc.
|
-3.69 USD
|
-2801.897%
|
|
Celcuity Inc.
|
-2.69 USD
|
-3880.669%
|
|
Virax Biolabs Group Limited
|
-3.36 USD
|
-3086.905%
|
|
Cibus, Inc.
|
-25.95 USD
|
-312.64%
|
|
Eledon Pharmaceuticals, Inc.
|
-0.00 USD
|
-6692400.0%
|
|
eFFECTOR Therapeutics, Inc.
|
-16.37 USD
|
-554.123%
|
|
IN8bio, Inc.
|
-1.00 USD
|
-10608.0%
|
|
Kodiak Sciences Inc.
|
-4.97 USD
|
-2054.527%
|
|
Annexon, Inc.
|
-1.77 USD
|
-5949.718%
|
|
Adverum Biotechnologies, Inc.
|
-11.62 USD
|
-821.515%
|
|
Assembly Biosciences, Inc.
|
-13.38 USD
|
-700.299%
|
|
Avalo Therapeutics, Inc.
|
-113.58 USD
|
5.723%
|
|
Ionis Pharmaceuticals, Inc.
|
-2.56 USD
|
-4082.813%
|
|
Eyenovia, Inc.
|
-0.66 USD
|
-16124.242%
|
|
Puma Biotechnology, Inc.
|
0.46 USD
|
23378.261%
|
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
-118351.327%
|
|
Xilio Therapeutics, Inc.
|
-2.78 USD
|
-3751.799%
|
|
Arcellx, Inc.
|
-1.47 USD
|
-7184.354%
|
|
Cardiff Oncology, Inc.
|
-0.93 USD
|
-11413.978%
|
|
Enanta Pharmaceuticals, Inc.
|
-6.38 USD
|
-1578.37%
|
|
Regulus Therapeutics Inc.
|
-1.58 USD
|
-6677.215%
|
|
Moolec Science SA
|
-1.50 USD
|
-7038.667%
|
|
Acumen Pharmaceuticals, Inc.
|
-1.08 USD
|
-9814.815%
|
|
Geron Corporation
|
-0.32 USD
|
-33362.5%
|
|
LAVA Therapeutics N.V.
|
-1.57 USD
|
-6720.382%
|
|
Royalty Pharma plc
|
3.41 USD
|
3240.176%
|
|
Atea Pharmaceuticals, Inc.
|
-1.63 USD
|
-6469.325%
|
|
Greenwich LifeSciences, Inc.
|
-0.69 USD
|
-15418.841%
|
|
TFF Pharmaceuticals, Inc.
|
-11.85 USD
|
-803.629%
|
|
Mersana Therapeutics, Inc.
|
-1.48 USD
|
-7135.135%
|
|
Humacyte, Inc.
|
-1.07 USD
|
-9907.477%
|
|
Structure Therapeutics Inc.
|
-2.44 USD
|
-4288.525%
|
|
89bio, Inc.
|
-2.00 USD
|
-5254.0%
|
|
PMV Pharmaceuticals, Inc.
|
-1.44 USD
|
-7336.111%
|
|
Avenue Therapeutics, Inc.
|
-73.60 USD
|
-45.489%
|
|
Genelux Corporation
|
-1.16 USD
|
-9131.034%
|
|
Trevi Therapeutics, Inc.
|
-0.29 USD
|
-36824.138%
|
|
Lexicon Pharmaceuticals, Inc.
|
-0.80 USD
|
-13285.0%
|
|
Notable Labs, Ltd.
|
-5.03 USD
|
-2028.827%
|
|
Liquidia Corporation
|
-1.21 USD
|
-8749.587%
|
|
Mustang Bio, Inc.
|
-6.00 USD
|
-1684.667%
|
|
Immunovant, Inc.
|
-1.88 USD
|
-5595.745%
|
|
Quantum-Si incorporated
|
-0.68 USD
|
-15647.059%
|
|
Arbutus Biopharma Corporation
|
-0.44 USD
|
-24236.364%
|
|
DiaMedica Therapeutics Inc.
|
-0.60 USD
|
-17746.667%
|
|
Vera Therapeutics, Inc.
|
-2.25 USD
|
-4659.111%
|
|
Acasti Pharma Inc.
|
-1.35 USD
|
-7831.852%
|
|
MiNK Therapeutics, Inc.
|
-0.65 USD
|
-16373.846%
|
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
-746.482%
|
|
Xenon Pharmaceuticals Inc.
|
-2.73 USD
|
-3822.344%
|
|
Elevai Labs, Inc. Common Stock
|
-0.40 USD
|
-26670.0%
|
|
NeuroBo Pharmaceuticals, Inc.
|
-2.46 USD
|
-4252.846%
|
|
Tempest Therapeutics, Inc.
|
-1.91 USD
|
-5506.283%
|
|
Soleno Therapeutics, Inc.
|
-2.36 USD
|
-4437.288%
|
|
PepGen Inc.
|
-3.30 USD
|
-3144.848%
|
|
Moleculin Biotech, Inc.
|
-15.07 USD
|
-610.551%
|
|
United Therapeutics Corporation
|
21.04 USD
|
608.935%
|
|
Nuvectis Pharma, Inc.
|
-1.43 USD
|
-7388.112%
|
|
Solid Biosciences Inc.
|
-4.83 USD
|
-2116.977%
|
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
-36824.138%
|
|
Immuneering Corporation
|
-1.88 USD
|
-5595.745%
|
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
-3925.564%
|
|
Silo Pharma, Inc.
|
-1.20 USD
|
-8823.333%
|
|
Belite Bio, Inc
|
-1.19 USD
|
-8898.319%
|
|
XOMA Corporation
|
-4.04 USD
|
-2550.495%
|
|
ARS Pharmaceuticals, Inc.
|
-0.57 USD
|
-18685.965%
|
|
Bionomics Limited
|
-1.02 USD
|
-10398.039%
|
|
Apogee Therapeutics, Inc.
|
-0.00 USD
|
-3149311.765%
|
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
-25395.238%
|
|
uniQure N.V.
|
-6.47 USD
|
-1555.023%
|
|
Cassava Sciences, Inc.
|
-2.32 USD
|
-4515.517%
|
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
-50890.476%
|
|
Poseida Therapeutics, Inc.
|
-1.37 USD
|
-7716.058%
|
|
Forte Biosciences, Inc.
|
-24.92 USD
|
-329.695%
|
|
Anebulo Pharmaceuticals, Inc.
|
-0.32 USD
|
-33362.5%
|
|
Enlivex Therapeutics Ltd.
|
-1.56 USD
|
-6764.103%
|
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
-118351.327%
|
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
-253.516%
|
|
FibroBiologics, Inc. Common Stock
|
-0.59 USD
|
-18049.153%
|
|
Altimmune, Inc.
|
-1.66 USD
|
-6350.602%
|
|
Amicus Therapeutics, Inc.
|
-0.51 USD
|
-20896.078%
|
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
-25395.238%
|
|
Compugen Ltd.
|
-0.21 USD
|
-50890.476%
|
|
Peak Bio, Inc.
|
- USD
|
Infinity%
|
|
Zevra Therapeutics, Inc.
|
-1.30 USD
|
-8136.923%
|
|
Benitec Biopharma Inc.
|
-5.36 USD
|
-1897.761%
|
|
Spyre Therapeutics, Inc.
|
-49.12 USD
|
-117.997%
|
|
NKGen Biotech, Inc. Common Stock
|
-5.38 USD
|
-1890.335%
|
|
Zura Bio Limited
|
-2.09 USD
|
-5023.445%
|
|
PolyPid Ltd.
|
-16.99 USD
|
-530.253%
|
|
Aileron Therapeutics, Inc.
|
-3.42 USD
|
-3030.994%
|
|
NKGen Biotech, Inc. Warrants
|
-5.38 USD
|
-1890.335%
|
|
Instil Bio, Inc.
|
-24.00 USD
|
-346.167%
|
|
argenx SE
|
-5.16 USD
|
-1975.194%
|
|
Immunome, Inc.
|
-5.38 USD
|
-1890.335%
|
|
Compass Therapeutics, Inc.
|
-0.33 USD
|
-32348.485%
|
|
Verona Pharma plc
|
-0.54 USD
|
-19729.63%
|
|
enGene Holdings Inc. Warrants
|
-4.51 USD
|
-2274.279%
|
|
Shattuck Labs, Inc.
|
-2.05 USD
|
-5123.415%
|
|
CervoMed Inc.
|
-0.82 USD
|
-12958.537%
|
|
LENZ Therapeutics, Inc.
|
-15.30 USD
|
-599.869%
|
|
Plus Therapeutics, Inc.
|
-4.24 USD
|
-2425.472%
|
|
Dianthus Therapeutics, Inc.
|
-8.45 USD
|
-1167.219%
|
|
Moolec Science SA
|
-1.50 USD
|
-7038.667%
|
|
Enveric Biosciences, Inc.
|
-8.09 USD
|
-1223.609%
|
|
Inovio Pharmaceuticals, Inc.
|
-6.09 USD
|
-1658.292%
|
|
AnaptysBio, Inc.
|
-6.08 USD
|
-1661.184%
|
|
Design Therapeutics, Inc.
|
-1.19 USD
|
-8898.319%
|
|
Leap Therapeutics, Inc.
|
-3.98 USD
|
-2590.452%
|
|
NeurAxis, Inc.
|
-4.03 USD
|
-2557.072%
|
|
Seelos Therapeutics, Inc.
|
-7.73 USD
|
-1285.252%
|
|
Lumos Pharma, Inc.
|
-4.18 USD
|
-2461.722%
|
|
Achilles Therapeutics plc
|
-1.74 USD
|
-6054.023%
|
|
enGene Holdings Inc. Common Stock
|
-4.51 USD
|
-2274.279%
|
|
180 Life Sciences Corp.
|
-52.60 USD
|
-103.574%
|
|
Opiant Pharmaceuticals, Inc.
|
0.68 USD
|
15847.059%
|
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
-27356.41%
|
|
Nutriband Inc.
|
-0.69 USD
|
-15418.841%
|
|
ORIC Pharmaceuticals, Inc.
|
-1.96 USD
|
-5363.265%
|
|
CG Oncology, Inc. Common stock
|
-15.65 USD
|
-584.217%
|
|
Fractyl Health, Inc. Common Stock
|
-1.98 USD
|
-5308.081%
|
|
Rani Therapeutics Holdings, Inc.
|
-1.33 USD
|
-7951.128%
|
|
MoonLake Immunotherapeutics
|
-0.73 USD
|
-14568.493%
|
|
Palisade Bio, Inc.
|
-27.01 USD
|
-296.446%
|
|
Tourmaline Bio, Inc.
|
-8.87 USD
|
-1107.215%
|
|
Beam Therapeutics Inc.
|
-1.72 USD
|
-6125.581%
|
|
Neurogene Inc.
|
-2.83 USD
|
-3683.746%
|
|
Mirum Pharmaceuticals, Inc.
|
-4.00 USD
|
-2577.0%
|
|
AEON Biopharma, Inc.
|
- USD
|
Infinity%
|
|
CARGO Therapeutics, Inc. Common Stock
|
-2.38 USD
|
-4399.16%
|
|
Sesen Bio, Inc.
|
-1.99 USD
|
-5280.905%
|
|
Enliven Therapeutics, Inc.
|
-2.01 USD
|
-5227.363%
|
|
Kiora Pharmaceuticals, Inc.
|
-24.25 USD
|
-341.567%
|
|
Iovance Biotherapeutics, Inc.
|
-1.89 USD
|
-5565.608%
|
|
Taysha Gene Therapies, Inc.
|
-0.96 USD
|
-11054.167%
|
|
Athira Pharma, Inc.
|
-3.10 USD
|
-3354.194%
|
|
Vaccinex, Inc.
|
-43.68 USD
|
-145.147%
|
|
HCW Biologics Inc.
|
-0.70 USD
|
-15197.143%
|
|
XOMA Corporation
|
-4.04 USD
|
-2550.495%
|
|
Nektar Therapeutics
|
-1.45 USD
|
-7284.828%
|
|
Arvinas, Inc.
|
-6.62 USD
|
-1517.523%
|
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
-26769900.0%
|
|
Merus N.V.
|
-3.00 USD
|
-3469.333%
|
|
Omega Therapeutics, Inc.
|
-1.80 USD
|
-5848.889%
|
|
Quince Therapeutics, Inc.
|
-0.84 USD
|
-12647.619%
|
|
Rezolute, Inc.
|
-1.33 USD
|
-7951.128%
|
|
Clene Inc.
|
-9.43 USD
|
-1035.525%
|
|
Indaptus Therapeutics, Inc.
|
-1.84 USD
|
-5719.565%
|
|
BeyondSpring Inc.
|
-0.54 USD
|
-19729.63%
|
|
Synlogic, Inc.
|
-8.81 USD
|
-1115.437%
|
|
Allarity Therapeutics, Inc.
|
-0.01 USD
|
-1039511.65%
|
|
Phio Pharmaceuticals Corp.
|
-46.87 USD
|
-128.462%
|
|
Peak Bio, Inc.
|
- USD
|
Infinity%
|
|
Werewolf Therapeutics, Inc.
|
-1.05 USD
|
-10098.095%
|
|
Krystal Biotech, Inc.
|
0.40 USD
|
26870.0%
|
|
Karyopharm Therapeutics Inc.
|
-1.25 USD
|
-8466.4%
|
|
SpringWorks Therapeutics, Inc.
|
-5.15 USD
|
-1979.223%
|
|
Lipella Pharmaceuticals Inc.
|
-0.77 USD
|
-13806.494%
|
|
MannKind Corporation
|
-0.04 USD
|
-239452.573%
|
|
Ikena Oncology, Inc.
|
-1.63 USD
|
-6469.325%
|
|
Cyclerion Therapeutics, Inc.
|
-8.99 USD
|
-1091.101%
|
|
Gyre Therapeutics, Inc.
|
-1.41 USD
|
-7494.326%
|
|
Gossamer Bio, Inc.
|
-1.18 USD
|
-8974.576%
|
|
CohBar, Inc.
|
-4.13 USD
|
-2492.736%
|
|
Cognition Therapeutics, Inc.
|
-0.86 USD
|
-12351.163%
|
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
-2590.452%
|
|
Legend Biotech Corporation
|
-2.94 USD
|
-3542.177%
|
|
Mural Oncology plc
|
-12.43 USD
|
-761.464%
|
|
Biora Therapeutics, Inc.
|
-7.87 USD
|
-1260.61%
|
|
PaxMedica, Inc. Common Stock
|
-11.00 USD
|
-873.455%
|
|
Disc Medicine, Inc.
|
-3.43 USD
|
-3021.866%
|
|
Champions Oncology, Inc.
|
-0.54 USD
|
-19729.63%
|
|
REGENXBIO Inc.
|
-6.02 USD
|
-1678.738%
|
|
Ensysce Biosciences, Inc.
|
-4.69 USD
|
-2183.156%
|
|
Anavex Life Sciences Corp.
|
-0.60 USD
|
-17746.667%
|
|
Cellectar Biosciences, Inc.
|
-3.11 USD
|
-3343.087%
|
|
Edgewise Therapeutics, Inc.
|
-1.57 USD
|
-6720.382%
|
|
Vaxart, Inc.
|
-0.57 USD
|
-18685.965%
|
|
PharmaCyte Biotech, Inc.
|
-1.80 USD
|
-5848.889%
|
|
Aldeyra Therapeutics, Inc.
|
-0.64 USD
|
-16631.25%
|
|
Cellectis S.A.
|
-1.77 USD
|
-5949.718%
|
|
Longeveron Inc.
|
-10.22 USD
|
-947.75%
|
|
Repare Therapeutics Inc.
|
-2.23 USD
|
-4701.794%
|
|
Sarepta Therapeutics, Inc.
|
-5.80 USD
|
-1746.207%
|
|
Inozyme Pharma, Inc.
|
-1.37 USD
|
-7716.058%
|
|
Revolution Medicines, Inc.
|
-3.86 USD
|
-2674.093%
|
|
Nymox Pharmaceutical Corporation
|
-0.07 USD
|
-145587.075%
|
|
Third Harmonic Bio, Inc.
|
-0.78 USD
|
-13628.205%
|
|
ArriVent BioPharma, Inc. Common Stock
|
-2.17 USD
|
-4834.562%
|
|
AN2 Therapeutics, Inc.
|
-2.74 USD
|
-3808.029%
|
|
Anixa Biosciences, Inc.
|
-0.32 USD
|
-33362.5%
|
|
Vertex Pharmaceuticals Incorporated
|
14.05 USD
|
862.135%
|
|
Denali Therapeutics Inc.
|
-1.06 USD
|
-10001.887%
|
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
-20103.774%
|
|
Veru Inc.
|
-1.10 USD
|
-9634.545%
|
|
Corvus Pharmaceuticals, Inc.
|
-0.56 USD
|
-19021.429%
|
|
Cingulate Inc.
|
-311.99 USD
|
65.678%
|
|
Passage Bio, Inc.
|
-1.86 USD
|
-5656.989%
|
|
Context Therapeutics Inc.
|
-1.50 USD
|
-7038.667%
|
|
Exicure, Inc.
|
-2.11 USD
|
-4974.882%
|
|
Day One Biopharmaceuticals, Inc.
|
-2.37 USD
|
-4418.143%
|
|
Oramed Pharmaceuticals Inc.
|
-0.97 USD
|
-10939.175%
|
|
Scinai Immunotherapeutics Ltd.
|
-16.62 USD
|
-544.284%
|
|
Rhythm Pharmaceuticals, Inc.
|
-3.20 USD
|
-3246.25%
|
|
Nuvalent, Inc.
|
-2.17 USD
|
-4834.562%
|
|
ABVC BioPharma, Inc.
|
-2.43 USD
|
-4306.584%
|
|
Carisma Therapeutics, Inc.
|
-2.59 USD
|
-4034.363%
|
|
Unicycive Therapeutics, Inc.
|
-1.28 USD
|
-8265.625%
|
|
OmniAb, Inc.
|
-0.51 USD
|
-20896.078%
|
|
Anew Medical, Inc.
|
0.14 USD
|
76585.714%
|
|
Fennec Pharmaceuticals Inc.
|
-0.60 USD
|
-17746.667%
|
|
Lipocine Inc.
|
-3.14 USD
|
-3310.191%
|
|
Lexeo Therapeutics, Inc. Common Stock
|
-2.49 USD
|
-4200.402%
|
|
Nautilus Biotechnology, Inc.
|
-0.51 USD
|
-20896.078%
|
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
-1301.571%
|
|
G1 Therapeutics, Inc.
|
-0.93 USD
|
-11413.978%
|
|
Bellerophon Therapeutics, Inc.
|
-2.08 USD
|
-5048.077%
|
|
Sage Therapeutics, Inc.
|
-9.05 USD
|
-1083.204%
|
|
Ocugen, Inc.
|
-0.26 USD
|
-41084.615%
|
|
Mind Medicine (MindMed) Inc.
|
-2.44 USD
|
-4288.525%
|
|
Q32 Bio Inc.
|
-35.16 USD
|
-204.551%
|
|
Brainstorm Cell Therapeutics Inc.
|
-0.40 USD
|
-26670.0%
|
|
Alumis Inc. Common Stock
|
-2.99 USD
|
-3481.271%
|
|
Equillium, Inc.
|
-0.38 USD
|
-28078.947%
|
|
Kyverna Therapeutics, Inc.
|
-0.00 USD
|
-107079900.0%
|
|
Coya Therapeutics, Inc.
|
-0.79 USD
|
-13454.43%
|
|
CNS Pharmaceuticals, Inc.
|
-251.35 USD
|
57.398%
|
|
Galera Therapeutics, Inc.
|
-1.33 USD
|
-7951.128%
|
|
Evelo Biosciences, Inc.
|
-26.28 USD
|
-307.458%
|
|
Comera Life Sciences Holdings, Inc.
|
-1.76 USD
|
-5984.091%
|
|
Dominari Holdings Inc.
|
-4.38 USD
|
-2344.749%
|
|
Edesa Biotech, Inc.
|
-2.93 USD
|
-3554.608%
|
|
vTv Therapeutics Inc.
|
-9.71 USD
|
-1002.781%
|
|
Bio-Techne Corporation
|
1.07 USD
|
10107.477%
|
|
Agios Pharmaceuticals, Inc.
|
-6.33 USD
|
-1591.627%
|
|
Harmony Biosciences Holdings, Inc.
|
2.17 USD
|
5034.562%
|
|
Prelude Therapeutics Incorporated
|
-2.02 USD
|
-5200.99%
|
|
Candel Therapeutics, Inc.
|
-1.31 USD
|
-8074.046%
|
|
iTeos Therapeutics, Inc.
|
-3.15 USD
|
-3299.365%
|
|
Nkarta, Inc.
|
-2.40 USD
|
-4361.667%
|
|
BioCardia, Inc.
|
-8.19 USD
|
-1207.448%
|
|
Iterum Therapeutics plc
|
-2.96 USD
|
-3517.568%
|
